Inside Health Reform: In First DQSA Warning Letters, FDA Targets Compounders Without Patient Prescriptions

In First DQSA Warning Letters, FDA Targets Compounders Without Patient Prescriptions (Daily News - 01-30-2014)

FDA issued two warning letters to drug compounders in recent weeks chastising them for lacking patient-specific prescriptions -- the first letters citing the recently passed Drug Quality and Security Act and delving into a point of conflict between state and federal laws.